Abstract
We set out to determine the levels of Mycobacterium tuberculosis resistance to first- and second-line TB drugs in an urban population in Zambia. Sputum samples were collected consecutively from all smear-positive, new and previously treated patients, from four diagnostic centres in Ndola between January and July 2006. Drug susceptibility testing was performed using the proportion method against four first- and two second-line TB drugs. Results. Among 156 new cases, any resistance was observed to be 7.7%, monoresistance to isoniazid and rifampicin was 4.5% and 1.3%, respectively. Of 31 retreatment cases, any resistance was observed to be 16.1%, monoresistance to isoniazid and rifampicin was 3.3% for each drug, and one case of resistance to both isoniazid and rifampicin (multidrug resistance) was detected. No resistance to kanamycin or ofloxacin was detected. Conclusion. Although not representative of the country, these results show low levels of drug resistance in a community with a long-standing DOTS experience. Resource constrained countries may reduce TB drug resistance by implementing community-based strategies that enhance treatment completion.
References
Apr 1, 1992·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J S JarallahS A al-Shammari
Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine·C M NolanS V Goldberg
Feb 1, 1996·American Journal of Respiratory and Critical Care Medicine·M LutfeyB N Kreiswirth
Mar 1, 1997·Journal of Clinical Microbiology·A TelentiS T Cole
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F MarchG Prats
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S S MunsiffT R Frieden
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·R RidzonI M Onorato
Feb 2, 1999·American Journal of Respiratory and Critical Care Medicine·L SandmanS Bonk
Jan 25, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Ramaswamy, J M Musser
Oct 12, 2000·The Journal of Infection·A P DaviesS H Gillespie
Sep 8, 2001·AIDS·O O SimooyaR Musonda
Nov 10, 2006·Journal of Clinical Microbiology·Leen RigoutsFrançoise Portaels
Oct 24, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·A UmubyeyiF Portaels
May 24, 2008·The Journal of Infectious Diseases·Pablo BifaniBarry N Kreiswirth
Jun 27, 2008·BMC Microbiology·Susanne HomolkaStefan Niemann
Apr 1, 1969·The Journal of Cell Biology·G C Budd, M M Salpeter
Jan 1, 1915·The Journal of Experimental Medicine·S A Petroff
Citations
Mar 14, 2013·PloS One·Sebastian M MbomaAmelia C Crampin
Sep 17, 2013·Tropical Medicine & International Health : TM & IH·Nathan KapataAlimuddin Zumla
Aug 1, 2015·Tropical Medicine & International Health : TM & IH·Nathan KapataHelen Ayles
May 17, 2014·Tuberculosis Research and Treatment·Berhanu SeyoumAbraham Aseffa
Nov 24, 2012·The Lancet Infectious Diseases·Gyanshankar P Mishra
Apr 6, 2016·PloS One·Leonela VillegasCarlos Seas
Sep 26, 2017·PloS One·Baba Maiyaki MusaMuktar H Aliyu
Jul 20, 2016·BMC Public Health·Shallo Daba HamusseBernt Lindtjørn
Oct 2, 2020·Journal of Clinical Microbiology·Joseph SheaKimberlee A Musser